Erik Harris - 03 Oct 2024 Form 3 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Director
Signature
/s/ Sanjay Subramanian, as attorney-in-fact for Erik Harris
Issuer symbol
INZY
Transactions as of
03 Oct 2024
Net transactions value
$0
Form type
3
Filing time
07 Oct 2024, 16:35:47 UTC
Previous filing
04 Jun 2024
Next filing
04 Mar 2025

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24.1 Power of Attorney